Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Urtasun, M.
Right arrow Articles by Lopez de Munain, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urtasun, M.
Right arrow Articles by Lopez de Munain, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 121, Issue 9 1735-1747, Copyright © 1998 by Oxford University Press


ARTICLES

Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain)

M Urtasun, A Saenz, C Roudaut, JJ Poza, JA Urtizberea, AM Cobo, I Richard, F Garcia Bragado, F Leturcq, JC Kaplan, JF Marti Masso, JS Beckmann and A Lopez de Munain
Department of Neurology, Hospital Ntra. Sra. Aranzazu, San Sebastian, Basque Country, Spain. murtasuno@meditex.es

The concept of limb-girdle muscular dystrophy (LGMD) is changing rapidly due to the advances in molecular genetics. Recently, seven different gene loci have been described, demonstrating that limb-girdle muscular dystrophy is a heterogeneous syndrome, which includes different diseases with a similar phenotype. In isolated populations which have little genetic exchange with neighbouring populations, an accumulation of cases may be found. We carried out an epidemiological study in Guipuzcoa, a small mountainous Basque province in northern Spain, and found the highest prevalence rate of LGMD described so far: 69 per million. Genetic studies demonstrated that 38 cases corresponded to the LGMD2A type, due to calpain-3 gene mutations. Only one patient with alpha-sarcoglycanopathy was found, and in 12 patients the genetic defect was not identified. Moreover, the particular calpain-3 mutation predominant in Basque chromosomes (exon 22, 2362AG-->TCATCT), has only been rarely found in the rest of the world. This observation strongly suggests a founder effect in the indigenous population of Guipuzcoa. The clinical characteristics of the patients with calpain-3 gene mutations were quite homogeneous and different from the other groups (sarcoglycanopathy and unknown gene defect), allowing for a precise clinical diagnostic. The disease onset was between the ages of 8 and 15 years, in most cases in the pelvic girdle, and the patients became wheelchair-bound between 11 and 28 years after onset. No pseudohypertrophy of calves or contractures were observed. No clear correlations were found between the nature and site of the mutation and the resulting phenotype.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
I. Kramerova, E. Kudryashova, B. Wu, S. Germain, K. Vandenborne, N. Romain, R. G. Haller, M. A. Verity, and M. J. Spencer
Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle
Hum. Mol. Genet., September 1, 2009; 18(17): 3194 - 3205.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. J. Groen, R. Charlton, R. Barresi, L. V. Anderson, M. Eagle, J. Hudson, M. S. Koref, V. Straub, and K. M. D. Bushby
Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A
Brain, December 1, 2007; 130(12): 3237 - 3249.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Zatz and A. Starling
Calpains and Disease
N. Engl. J. Med., June 9, 2005; 352(23): 2413 - 2423.
[Full Text] [PDF]


Home page
BrainHome page
A. Saenz, F. Leturcq, A. M. Cobo, J. J. Poza, X. Ferrer, D. Otaegui, P. Camano, M. Urtasun, J. Vilchez, E. Gutierrez-Rivas, et al.
LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene
Brain, April 1, 2005; 128(4): 732 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Boito, M Fanin, G Siciliano, C Angelini, and E Pegoraro
Novel sarcoglycan gene mutations in a large cohort of Italian patients
J. Med. Genet., May 1, 2003; 40(5): e67 - 67.
[Full Text] [PDF]


Home page
NeurologyHome page
M. Fanin, E. Pegoraro, C. Matsuda-Asada, R.H. Brown Jr., and C. Angelini
Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy
Neurology, March 13, 2001; 56(5): 660 - 665.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P. Dinçer, Z. Akçören, E. Demir, I. Richard, O. Sancak, G. Kale, E. Tan, J A. Urtizberea, and J. S Beckmann
A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families
J. Med. Genet., May 1, 2000; 37(5): 361 - 367.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
K. M. D. Bushby
The limb-girdle muscular dystrophies--multiple genes,multiple mechanisms
Hum. Mol. Genet., September 1, 1999; 8(10): 1875 - 1882.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. M. D. Bushby
Making sense of the limb-girdle muscular dystrophies
Brain, August 1, 1999; 122(8): 1403 - 1420.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.